Our role in pharma
Our goal at Roche Products Ltd is to achieve better outcomes for more patients faster, through the development and availability of treatments for some of the most serious diseases and conditions.
:quality(90)/)
Roche UK’s Pharmaceutical Business
With a campus in Welwyn Garden City, Hertfordshire, our pharmaceutical business plays a significant role in advancing healthcare in the UK. Our UK site is a key part of Roche’s global research and development (R&D) programme, the largest of any healthcare company in the world. A key reason for this is the wealth of scientific talent in the UK, and the key partnerships that we have with universities, the NHS, regulators and Government. In 2023, we invested over £347 million into UK research and development, which equates to 3.9% of the total UK government spending on healthcare research.
Our passion for improving the lives of people across the UK is reflected in the next stage of the journey in developing new treatments - taking them from the lab to the real world. Since 2018, every single new Roche medicine that we’ve brought to market in the UK is available on the NHS.
Key statistics
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
Roche UK Impact study
January 2025 / M-GB-00021189
M-GB-00024468 Date of Preparation January 2026
:quality(90)/)